Clinical trial

The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy

NCT07475065

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention DLBS1033 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Comparator: Placebo + Standard Therapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE2, PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-03-01

PhasePHASE2 / PHASE3

Conditions

Diabetic Polyneuropathyverified · MONDO: diabetic polyneuropathy

Peripheral Nervous System Diseasesunresolved

Peripheral Neuropathyverified · MONDO: peripheral neuropathy

Diabetes Mellitusverified · MONDO: diabetes mellitus

Interventions

DLBS1033DRUG

Placebo Comparator: Placebo + Standard TherapyDRUG

Sponsors & collaborators

Universitas Sebelas Maretlead sponsor

Dexa Medica Groupcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07475065 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.